MONTREAL, July 6, 2021 /CNW Telbec/ - Lumiera
Health Inc. (TSXV: NHP) (the "Company"
or "Lumiera "), a company specializing in the
development and commercialization of natural health products, is
pleased to announce the results of its annual general and special
meeting of shareholders (the "Meeting"), which was held
June 30, 2021 by webcast. All of the
nominees listed in the Company's management information circular
dated May 21, 2021, were elected as
directors.
Detailed results of the vote for the election of directors are
set out below:
Nominee
|
Votes FOR
|
%FOR
|
Votes Withheld
|
%Withheld
|
Marie Bélanger
|
54,911,018
|
99.57%
|
238,750
|
0.43
|
Kevin Cole
|
46,127,089
|
83.64%
|
9,022,679
|
16.36
|
Nathalie Nasseri
|
54,911,018
|
99.57%
|
238,750
|
0.43
|
Carlos Ponce
|
46,127,089
|
83.64%
|
9,022,679
|
16.36
|
Simon
Castonguay
|
46,127,089
|
83.64%
|
9,022,679
|
16.36
|
All other matters presented for shareholder approval at the
Meeting were approved, as follows:
- to appoint Richter LLP, Chartered Accountants as the auditors
of the Corporation and to authorize the directors to fix the
auditors' remuneration;
- to consider, and if deemed advisable, to pass, with or without
variation, an ordinary resolution confirming re-approval of the
Corporation's incentive stock option plan;
About Lumiera Health Inc.
Lumiera specializes in the development and commercialization of
natural health products for the healthcare industry. The Company
sells both oral and topical botanical agents to help manage unmet
medical needs through its Holizen Laboratories division. Lumiera is
also developing and commercializing a unique portfolio of products
acting on the endocannabinoid system and providing innovative
solutions for chronic pain and inflammation. The Company is a
pioneer in the health and pain management innovation space and the
Lumiera brand is rooted in the core brand values of science, nature
and compassion. Passionate about making people feel better,
we deliver trustworthy and scientifically proven solutions that
work with the body's own system.
For more information visit: www.lumiera.ca.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward-looking information
Certain statements contained in this press release constitute
"forward-looking information" as such term is defined in applicable
Canadian securities legislation. The words "may", "would", "could",
"should", "potential", "will", "seek", "intend", "plan",
"anticipate", "believe", "estimate", "expect" and similar
expressions indicate such "forward-looking
information" as they relate to Lumiera. All statements other
than statements of historical fact may be forward-looking
information. Such statements reflect Lumiera' current views and
intentions with respect to future events, and current information
available to Lumiera, and are subject to certain risks,
uncertainties and assumptions. Such risks and uncertainties
include, among others, the risk factors included in Lumiera' annual
management's discussion and analysis for the year
ended November 30, 2020,
which is available under the issuer's SEDAR profile
at www.sedar.com. Material factors or assumptions
were applied in providing forward-looking information. Many factors
could cause the actual results, performance or achievements that
may be expressed or implied by such forward-looking information to
vary from those described herein should one or more of these risks
or uncertainties materialize. Should any factor affect Lumiera in
an unexpected manner, or should assumptions underlying the
forward-looking information prove incorrect, the actual results or
events may differ materially from the results or events predicted.
Any such forward-looking information is expressly qualified in its
entirety by this cautionary statement. Moreover, Lumiera does not
assume responsibility for the accuracy or completeness of such
forward-looking information. The forward-looking information
included in this press release is made as of the date of this press
release and Lumiera undertakes no obligation to publicly update or
revise any forward-looking information, other than as required by
applicable law.
SOURCE Lumiera Health Inc.